William Weintraub MD, MACC, FAHA, FESC

Dr. William S. Weintraub serves as the director of population health research for the MedStar Health Research Institute where he examines health outcomes within specific patient populations. Most recently, he served as primary investigator and chair of the presentation and publication committee of the CDC-sponsored Community Research Partnership, a MedStar Health surveillance study on COVID-19 community transmission and exposure.

In addition, Dr. Weintraub is a professor of medicine at Georgetown University. Previously he was a Professor of Medicine at Jefferson University in Philadelphia and the John H. Ammon Chair in Cardiology and director of the cardiology section at Christiana Health Care System in Newark, Delaware. Dr. Weintraub also holds appointments as an adjunct professor of health sciences at the University of Delaware and professor of medicine emeritus and professor of public health emeritus at Emory University School of Medicine.

Dr. Weintraub received his MD degree from Johns Hopkins in 1975. After training at Boston University, Mount Sinai Hospital in New York, and the University of Pennsylvania in Philadelphia, he was appointed to the University of Pennsylvania faculty in 1980. He was recruited to Emory University in 1986 to direct efforts in outcomes research in cardiovascular medicine, overseeing the Emory cardiovascular databank. He founded the Emory Center for Outcomes Research (ECOR) in the mid-1990s, publishing over 200 papers while on the faculty at Emory.

While at Emory, Dr. Weintraub was appointed the first chairman of the National Cardiovascular Data Registry of the American College of Cardiology. Dr. Weintraub served as chairman of the steering committee for the ACC NCDR Cath-PCI registry as well as on the ACC NCDR management board. Dr. Weintraub has served on multiple committees for the ACC and the American Heart Association. He has served as the President of the Great Rivers Affiliate of the ACC and has won multiple awards from the ACC and AHA, including becoming a Master of the American College of Cardiology and Science Advocate of the Year from the American Heart Association.

In addition to working on registries, Dr. Weintraub has been working on clinical trials since the 1980s. He was a principal investigator on EAST, LRT, RESTORE, TACTICS-TIMI 18, SoS, EPHESUS, CURE, CREDO, and COURAGE. Activities in all of these trials have involved multicenter collaborations. The activities on both registries and clinical trials have afforded Dr. Weintraub extensive experience in both leading multi-institutional research activities and participating in the leadership group.

Dr. Weintraub has specialized knowledge and skill in health status assessment and healthcare economics. He has been involved in the economic analysis for each of the trials noted above and in the quality of life analysis for TACTICS-TIMI 18, SoS, EPHESUS, COURAGE, and REDUCE-IT. Dr. Weintraub was one of the first in cardiovascular medicine to develop an economic analysis alongside a clinical trial. Dr. Weintraub remains active in this endeavor.